Annual Meeting Program Committee Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, share a few highlights from today’s schedule to help you plan your day.

---

Welcome to another great day of learning and collaborating at the American Association for Cancer Research Annual Meeting. Today is the last full day for the Exhibit Show, so make your way to the hall to see what’s creating the latest buzz in cancer research.

The fourth plenary session, Evolution of the Genome, Microenvironment, and Host through Metastasis, will start the day at 8 a.m. in Hall GH at the San Diego Convention Center. You are invited to submit questions online about the presentations, and those questions will be answered during the panel discussion.

If you weren’t able to attend the 2023 San Antonio Breast Cancer Symposium (SABCS) virtually or in person, the Annual Meeting features a new session today that provides an overview of the meeting. Updates from SABCS 2023 will be at 10:15 a.m. PT in Room 28. You can read more about it in AACR Annual Meeting News.

An expert panel will discuss clinical management of lung cancer in non-smokers in the Advances in Organ Site Research session Dharma Master Jiantai Advances in Lung Cancer Research Session: Deciphering Lung Cancer in Non-smokers – Dedicated to the Memory of Richard H. Creech. The session takes place at 12:30 p.m. PT in Ballroom 6 A. You can find more information about it in this AACR Annual Meeting News article.

Computational oncology leverages large-scale and multi-modal data to develop machine learning and artificial intelligence models with the goal of personalizing medicine and patient stratification. The Advances in Technologies session Frontiers in Computational Oncology: Harnessing Multimodal Data for Biological Insight will cover real-world data and look more closely at this emerging field.

National Cancer Institute leaders will discuss cancer breakthroughs and the importance of securing support from lawmakers for the NCI and National Institutes of Health in the session The Cancer Moonshot: Opportunities to Fulfill the Vision of the National Cancer Plan – Dedicated to the Memory of Sen. Dianne Feinstein, set for 2:30 p.m. PT in Room 1. Danielle Carnival, PhD, from the Executive Office of the President in Washington, D.C., will present along with a panel of distinguished leaders and scientists.

Major symposia and minisymposia today feature a wide variety of scientific topics. More than a dozen minisymposia start at 2:30 p.m. PT today; they feature topics from liquid biopsy to metabolism. Two major symposia of note:

• Molecular Glues, PROTACs, and Next-Gen Degraders: Discovery and Early Preclinical Advances, at 10:15 a.m. PT in Room 31, will showcase preclinical advances for new oncology targets and their respective indications.
• Discovering and Broadening the Therapeutic Modalities of Immune Therapy, at 12:30 p.m. PT in Hall GH, will look at mechanisms that contribute to the success of immune therapies and methods under investigation that would broaden development.

There are five forums this evening at 5 p.m. PT, including Opportunities and Challenges in Leveraging Real-World Data to Accelerate Evidence Generation in Ballroom 6 CF. The final Meet the Expert session, with Gerrit A. Meijer, MD, PhD, of the Netherlands Cancer Institute, also begins at 5 p.m. PT, in Ballroom 6 DE.

Tomorrow promises to be another exciting day of science, with a morning plenary session on artificial intelligence and the final plenary session of the Annual Meeting, the AACR Annual Meeting 2024 Highlights: Vision for the Future, which recaps several important findings featured throughout the meeting, at 12 p.m. PT in Ballroom 20. Enjoy your last full day of programming, and we’ll see you tomorrow!